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Background: The UK human papillomavirus (HPV) vaccination programme aims to provide girls aged
12–13 with protection against two of the most carcinogenic strains (types 16 and 18) of this sexually
transmittedviruswhich together account for70%of casesof cervical cancer.Despiteevidence suggestinga
general lack of knowledge aboutHPVand its linkwith cervical cancer, vaccineuptake rateswere generally
high in theUK for theﬁrst year of theHPVvaccinationprogramme. In countries that implemented theHPV
programme ahead of the UK, studies have found that girls’ and parents’ levels of awareness about HPV
have increased since implementation of the programme but that knowledge continues to be limited. This
study offers some of the ﬁrst insights from the UK into adolescent girls’ understandings of HPV, its link
with cervical cancer, and experiences of vaccination, since the programmewas introduced in September
2008.
Method: Eighteen focus groups were conducted between December 2009 andMay 2010 with schoolgirls
aged between 12 and 18 living in various parts of the UK.
Results: Eighty seven girls participated in these discussions. Typically, girls knew very little about HPV or
how they could best protect themselves from HPV infection. Although many of the girls linked HPV to
cancer, only half speciﬁcally associated itwith cervical cancer.Most girls hadno ideahow long the vaccine
would offer them protection. They assumed that HPV vaccination must be important for their health
because it was recommended by people they trusted, namely parents and immunisation experts. Just
over half of the girls were aware that in the future they would need to attend for cervical screening. Key
concernswhich girls expressed aboutHPVvaccination reﬂected their anxieties about needles, anticipated
pain on injection, privacy during vaccination and fears about needle cleanliness.
Conclusion: Our data point to a need to continue to address gaps in knowledge about HPV and to provide
information to address girls’ concerns about vaccination. This could be achieved through targeted cam-
paignmaterials and by ensuring those involved in delivering the programme are aware of girls’ anxieties
to prevent limited knowledge and fears about vaccination becoming barriers either to HPV vaccination.. Introduction
In the UK a vaccination programme against the human papillo-
avirus (HPV)was introduced in September 2008. The programme
ims to provide three doses of HPV vaccine to girls before they
each an age when the risk of HPV infection increases [1]. The pro-
ramme currently offers girls aged 12–13 protection against two
f the most carcinogenic strains of this sexually transmitted virus
types 16 and 18) which together are responsible for 70% of cases
f cervical cancer [2]. A concurrent three year catch up programme
s also being offered to girls aged 14–18 years. The latest uptake
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rates for all three doses are high among the younger cohort of girls
(aged 12–13) in England 76.4% [3] and in Scotland 89% [4]. Uptake
of all three doses among the oldest cohort targeted for the catch-
up programme (17–18 years) has also been high in Scotland (85%),
but lower uptake for these older age groups has been achieved in
England (38.9%) [5].
These HPV vaccine uptake rates among the younger cohort of
girls indicate high levels of acceptability of the HPV vaccine pro-
gramme to date in the UK. This is despite the evidence of a general
lack of knowledge among British women about HPV and its link
with cervical cancer. For example, in a survey of 400 female uni-
Open access under CC BY license.versity employees just 30% had heard of HPV and only 11% knew
of its causal association with cervical cancer [6]. Similarly, in a
survey of women attending a Well Woman clinic in London (UK)
(n=1032) about30% recognisedHPVonly inname.On furtherques-
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ioning, less than half knew of the link with cervical cancer and
here was confusion about whether condoms or oral contracep-
ives could prevent HPV infection [7]. Similarly, in a representative
ample of British women (n=1620) aged 16–97 years, a quarter
f respondents were aware of HPV, and awareness was lower in
hose with less formal education [8]. Studies of parental attitudes
o HPV vaccination have also found a lack of knowledge about HPV,
ut have nonetheless indicated support for the introduction of the
accination programme [9,10]. Whilst it is important to note the
igh levels of support for the HPV vaccine despite limited knowl-
dge of its role in the aetiology of cervical cancer, this balance could
hift in the future. Studies of vaccine decision-making for younger
hildren suggest that once a vaccine is perceived to have potential
ide effects, then gaps in knowledge, myths and misunderstand-
ngs about the diseases to be prevented can shift the balance of
ecision-making [11], since perceptions of the severity and like-
ihood of contracting the disease are a key factor considered in
hether to accept a vaccine for younger children [12].
In recognition of the poor levels of knowledge about HPV, the
ublic awareness campaigns were launched in the UK to accom-
any the introduction of the vaccination programme. Their launch
oincided with intense media coverage of the diagnosis and death
rom cervical cancer of reality television star, Jade Goody. Whilst
his media coverage might have been assumed to provide useful
ackground information about cervical cancer and HPV in the lead
p to the introduction of the new vaccination programme, an anal-
sis of newsprint coverage of her illness and death found that it
endednot to include factual or educational information thatwould
elpwomentomakeconnectionsbetweenHPV, cervical cancerand
he new programme [13].
Post-implementation studies continue to reveal limited pub-
ic knowledge about HPV. A recent UK based interview study
xplored girls (aged 17–18 years) knowledge about HPV and atti-
udes towards HPV vaccination among girls who were part of the
catch-up’ vaccinationprogramme. Ten interviewswere carried out
etween March and May 2009. Williams et al.’s study found that
ost girls had limited understanding of HPV and HPV vaccination,
nd were uncertain about the need for the vaccine both in terms of
erceived risk [14]. Similarly, a study of HPV knowledge following
he implementationof theHPVvaccinationprogramme inAustralia
ound low levels of knowledge [15], and a US study conducted
fter publicity about the HPV vaccine produced by the manufac-
urers showed an increase in the perceived need for the vaccine,
ut no improvement in knowledge and understandings about why
he vaccine was important [16]. In the UK public awareness about
PVafter implementationof thevaccinationprogrammestill needs
o be ascertained. This study therefore explores adolescent girls’
nderstandings of HPV and its link with cervical cancer, and their
xperiences of vaccination in the year following the introduction of
he vaccination programme, in order to identify gaps in knowledge
hich could have important implications for future cervical cancer
revention in the UK.
. Methods
.1. Sampling and recruitment
Eighteen focus groupswere conductedbetweenDecember 2009
nd May 2010 with schoolgirls aged between 12 and 18 years
iving in various parts of the UK. Purposive sampling was used
o recruit a diverse sample in terms of socio-economic circum-
tances (see Table 1). Girls were recruited through posters, leaﬂets
nd adverts which were placed in a range of community settings
ncluding educational, community, and leisure and sport facilities.
dverts in local newspapers and strategically chosen websites,29 (2011) 4409–4415
such as Facebook, Bebo, and Jo’s Trust (a cervical cancer support
website) invited interested parties to contact the researcher. Girls
were also recruited through community group leaders such as
Girl Guide leaders, community workers running youth groups in
socially deprived areas, school teachers or parents who been con-
tacted by the researchers or who had viewed an advert indicated
they would be interested in getting their youth group, class or
daughters involved. Each girl was given a £10 voucher for taking
part.
2.2. Data collection and analysis
A topic guide,whichwas developed from the literature andpilot
work, explored the following themes: knowledge and understand-
ings about HPV infection and its link to cervical cancer; beliefs
about safer sex andpersonal risk in relation toHPV;understandings
and concerns about HPV vaccination; vaccination experiences; and
understandings of the importance of cervical cancer screening. The
group discussions were facilitated by ES and lasted between 1 and
2h. All discussionswere audio recorded (with participants’ permis-
sion) and transcribed verbatim. To enable systematic comparisons
to be made across the large amounts of data, each transcript was
checked and imported into NVivo 7. Data were thematically coded
and systemically charted, following the principles of framework
analysis [17]. One of the beneﬁts of framework analysis is that
it allows a team of researchers to rigorously examine and cross-
compare data to identify common reasoning and themes, and ideas
that are less common or speciﬁc to certain subgroups or individ-
uals. Throughout the analysis attention was paid to any deviant
or contradictory cases [18] and to group dynamics using the full
transcripts supplemented by ﬁeld-note observations [19].
2.3. Reporting data
To report the datawe have selected quotes attributed to an indi-
vidual which are expressed concisely and typify responses around
key themes. We have also selected some extracts which convey
the types of interactions which occurred in the group discussion to
give a senseof the richdata gathered fromgroupdiscussions,whilst
being mindful of group effects and the fact that all conversation is
inﬂuenced by the context in which it is generated [20]. An advan-
tage of the focus groupmethod is that it can generate dynamic data
by encouraging discussion between groupmembers [21]; however
the chaotic nature of conversation in more animated groups can
make it difﬁcult to identify all the individual speakers and this was
a particularly challenging aspect of this study.
Ethical approval for the study was obtained from the research
ethics committee of the University of Glasgow’s Law, Business and
Social Sciences Faculty.
3. Results
Eighty seven girls took part in 18 focus group discussions, nine
of which were conducted in Scotland (Strathclyde and Lothian
regions) and nine in England (London region) (see Table 1). Partici-
pantswere aged between 12 and 18 years of age. Seventy eight girls
had been vaccinated against HPV, four had refused the HPV vacci-
nation, and four had delayed vaccination as they were undecided;
data were missing for one girl.
3.1. Understandings about HPV infectionTypically, participants knew very little about HPV infection and
its transmission. They were asked if they knew how to protect
themselves fromHPV infection. Some girlsmentioned theHPV vac-
cine, others mentioned that condomswould prevent transmission,
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Table 1
Characteristics of focus groups and their participants.
Focus group Recruited from Pseudonym Age Had HPV vaccination?
1 (S1) Afﬂuent area: Strathclyde Snowballing in community, website Lucy 14 Yes
Emily 14 Yes
Sarah 14 Yes
Lynn 14 Yes
Sammy 13 No
2 (S2) Afﬂuent area: Strathclyde Snowballing in community Louise 13 Yes
Sharron 13 Yes
Mandy 13 Yes
Eva 12 Yes
Henretta 13 Yes
3 (S3) Mixed area: Strathclyde Snowballing in community, website Emma 13 Yes
Megan 13 Yes
Jane 13 Yes
Elouise 13 Yes
Julie 13 Yes
4 (S4) Afﬂuent area: Lothian School Elaine 16 Yes
Carla 16 Yes
Fay 16 Yes
Bella 16 Yes
Kay 16 Yes
Millie 16 Yes
5 (S5) Mixed area: Strathclyde Community youth club Kim 14 Yes
Noelle 13 Yes
Lisa 15 Yes
6 (S7) Deprived area: Lothian School Lily 15 Yes
Nicola 14 Yes
Gillian 14 Yes
Olivia 14 Yes
Sheona 15 Yes
Nancy 15 Yes
Amy 14 Yes
Anna 14 Yes
Jess 15 Yes
Linsay 14 Yes
Beth 14 Yes
7 (S8) Deprived area: Lothian School Megan 16 Yes
Lottie 16 Yes
Bethan 16 Yes
8 (S9) Deprived area: Lothian School Lia 18 Yes
Sophie 17 Yes
Ava 17 Yes
Juliette 17 Yes
9 (S11) Deprived area: Lothian School Rachael 17 Yes
Becky 17 Yes
Sue 17 Yes
Jill 17 Yes
Katy 17 Yes
Kelly 17 Yes
10 (E1) Deprived area: London Community youth club Jordan 12 Undecided
Diane 13 Undecided
Kim 12 Undecided
Esther 13 Undecided
11 (E2) Deprived area, London Community youth club Tess 13 Yes
Joanne 13 Yes
Hannah 12 Yes
Tanith 14 Yes
12 (E3) Deprived area, London Community youth club Natalie 14 No
Fran 14 Yes
Clara 14 No
13 (E4) Deprived area, London Community youth club Dawn 16 Yes
Asha 16 Yes
14 (E5) Deprived area, London Community youth club Zora Missed missed
Sally 14 No
Lorne 16 Yes
Cathy 17 Yes
Claire 16 Yes
15 (E6) Afﬂuent area, Surrey Community youth club Annabel 13 Yes
Tess 13 Yes
Rosie 13 Yes
Vicky 13 Yes
Shelly 13 Yes
16 (E7) Afﬂuent area: Surrey Community youth club Rose 16 Yes
Pat 15 Yes
Lauren 15 Yes
Matty 16 Yes
Catherine 16 Yes
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Table 1 (Continued)
Focus group Recruited from Pseudonym Age Had HPV vaccination?
17 (E8) Afﬂuent area: Essex Community youth club Chloe 16 Yes
Cate 17 Yes
Lorna 16 Yes
Zoe 16 Yes
18 (E9) Afﬂuent area: Essex Community youth club Fiona 15 Yes
Izzy 15 Yes
Isla 16 Yes
Rhona 16 Yes
Catrina 16 Yes
Annie 15 Yes
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r that avoiding sexual intercourse altogether would offer the best
rotection from contracting HPV. It was common for the girls who
id know that HPV was sexually transmitted to believe that their
wn risk of contracting it was low because they associated HPV
nfection with girls who “sleep around” (FG S5: Noelle 13). Only
wo of the girls mentioned that they knew HPV infection is highly
revalent. Discussions aboutprevalence rates ofHPV tended to lead
nto conversations about whether HPV could be detected through
outine STI testing. Although no routine test for HPV infection is
vailable, it was common for girls to believe that boys were the
ector of infection and should be routinely tested for HPV and
iven treatment if infected. This notion arose spontaneously in
hree groups. Further discussion revealed that girls were apply-
ng their general knowledge about STI prevention to HPV, although
hey were also unsure about whether HPV testing really was part
f routine STI testing, as illustrated by the following extract from
ne group discussion:
Sally: Boys should be tested.
Lorne: But you won’t ﬁnd HPV in an STI screening.
Sally: What do you mean?
Lorne: They won’t be looking for it.
Sally: Cervical cancer?
Lorne: They might look for something else. How’s the clinic going
to tell you that he’s got cervical cancer?
Sally: I’m not sure. Can they?
Facilitator: No
(FG E5: Sally 14, Lorne 16)
This comment that boys could be screened for cervical cancer
ather than HPV infection went unchallenged by the group mem-
ers. This lack of a clear understanding of how HPV infection could
e prevented and what the girls could do to protect themselves
as particularly evident in the younger groups. For example, when
ne younger group was asked how they could protect themselves
gainst HPV infection, they replied:
Tess: Take the pill.
Joanne: That’s not going to help.
Hannah: The pill doesn’t help, does it, at all?
Facilitator: No
Joanne: That’s pregnancy protection not health protection
(FG E2: Tess 13, Joanne 13, Hannah 12)
.2. HPV and its link with cervical cancerAround half of the girls were aware that HPV infection could
ead to the development of cervical cancer, but therewas also some
onfusion about whether cancer could actually be prevented. As
ne girl considered:Michelle 15 Yes
ducted in England.
Cervical cancer. I thought it was just like any cancer, like kind of
like lung cancer, it just kind of appears. . . like oneminute you’re
all right and the nextminute it’s like you’ve got cancer. I thought
itwas like that, I thought cancerwasoneof those randomthings.
I didn’t know cancer could be caught like sexually transmitted
at all (FG S5: Lisa 15).
It was common for girls to discuss broader ideas about cancer
and to mention a belief that cancer was difﬁcult to control through
any preventative measures. As one girl commented: “it doesn’t
work inmybrain thatyoucanprotect against cancerbecause cancer
is meant to be one of those things that just happens and you can’t
stop it” (FG E8: Chloe 16). Although almost all of the girls were
aware that Jade Goody had died from cancer many were unaware
that she had had cervical cancer and fewmade any link to the HPV
vaccination programme.
3.3. Understandings of HPV vaccination
It was common for the girls to mention having read the infor-
mation leaﬂets about the HPV vaccination, but many reported that
their mothers had been most instrumental in making the decision
aboutwhether HPV vaccinationwas in their best interest. Typically
girls referred to the HPV vaccine as the ‘cancer jab’ but struggled
to provide more speciﬁc detail about what the vaccine protects
against. Girls within two groups knew that it protected against
some form of cancer but were not sure precisely which cancers (FG
S3, FG E4) Discussion in one group showed that they understood
that the vaccine would not provide complete protection from all
carcinogenic strains of HPV (FG E6), whilst another group believed
the opposite to be true: “I think it protects you against all the types
which cause cervical cancer” (FG S11: Kelly 17). Girls in another
group thought that the vaccine would stop them dying from but
not getting cervical cancer.
“I think the vaccine, doesn’t prevent you from having cervical
cancer. But it can, it stops you from getting it bad. Youmight not
get the full dose of cancer, but you still get a small dose” (FG E2:
Tess 13).
Most girls had no idea how long the vaccine would provide pro-
tection against HPV, and one girl questioned whether the vaccine
“might be a complete waste of time” (FG S7: Lily 15) given that
it only protects against two HPV strains out of a huge number of
possible strains. However, about a third of the girls did understand
that the vaccine protected against the most carcinogenic strains.
When girls were asked about how they thought the vaccine
worked and what the vaccine contained discussions tended to be
short, full of pauses and tentative guesses. Fewof the girls appeared
to have given any thought to this prior to being asked in these group
discussions. Among the few groups that did try to respond to this
question there was a misunderstanding that the vaccine contained
cancer cells. For example:
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Esther: And do you know the injection is a bit of the cervical
cancer?
Kim: That’s what I just said, the dead virus
Esther: Oh sorry. But it’s not dead, actually it’s alive
Jordan: It’s alive, no, for real, it’s alive?
Diane: So you get three different doses
Jordan: Oh goodness
(FG E1: Esther 13, Kim 12, Jordan 12, Diane 13)
Despite such fears about the possibility of a live virus or live
ancer cells being used in the vaccine, in general the safety of the
accine was not a primary concern and there was little discussion
f any long-term side-effects from the vaccine. There was also evi-
ence of high levels of trust in the Government and immunisation
xperts that this vaccine must be good for their future health (oth-
rwise it would not have been introduced). As Rose (FG 16) stated:
I think the people in charge, like Government’s health people have
ecided the jag is in our interest so I feel there’s no reason not to
et it”. Thus the vaccine was generally assessed by the girls to be of
ow risk and high beneﬁt to their health.
.4. Understandings about future cervical cancer prevention
Just over half of the girls were aware of cervical smear tests.
ost of these girls were also aware that in the future they would
eed to go for cervical smear tests themselves, although few knew
t what age they would be ﬁrst expected to attend for one. Most of
he girls who knew about smear tests had learnt about them from
heir mothers, for example when their mothers had talked about
eceiving their own appointment cards for screening. It was also
ommon for girls to recall that during their HPV vaccination school
urses had told them they would still need to go for smear tests
n the future. Some girls had heard that smear tests were unpleas-
nt butwere aware of its necessity. This seemedmost evidentwhen
heydiscussed JadeGoody’s untimely death and several groups dis-
ussed the fact that shehadmissed attending for a smear testwhich
ed to the late discovery of her cancer (FGS- E7, E8, E9, S4, S7, S11),
s illustrated by the following extract:
Anna: I think she [Goody] hadnae been for a smear or something.
Beth: But I would never no’ go for one, though. . . it would be quite
embarrassing.
Sheona: You need to go.
Lily:Well if I didn’t go, I’d feel dead like guilty, like it would be like
eating away at me. And then imagine if you didnae go for it and
that happened? Like, that’s quite bad. . . she could’ve stopped that
a lot sooner.
Sheona: Especially like her when you’ve got children
Olivia: Like I don’t understandwhy shewouldn’t go if it was going
to help her, I think she was a bit stupid.
(FG S7: Anna 14, Beth 14, Sheona 15, Lily 15, Olivia 14)
.5. Experiences of vaccination
One of the issues that the girls seemed most keen to discuss
as their experience of HPV vaccination. Whilst there were often
ilences and stilted conversation in discussion of their understand-
ngs about HPV infection and its prevention, conversation was
nimated and the girls frequently interrupted or spoke over each
therwhen recalling their experiences of receiving the vaccination.
his was particularly evident in relation to their fear of needles and
he pain of injection, the issue of privacy during vaccination, and
oncerns about needle cleanliness.
Across the focus groups, it was common for girls to discuss
eeling scared about getting the vaccine and worried about the
evel of pain caused by the needle. This was discussed in all of the29 (2011) 4409–4415 4413
groups and ranged from girls describing a mild sense of nervous-
ness, to feeling tearful or sick with anxiety. In four groups girls
talked hypothetically about refusing the HPV vaccine due to what
they described as ‘needle phobias’ but only one girl actually stated
that she had refused the vaccine because of a needle phobia. Girls
frequently described difﬁculty controlling a range of emotions in
front of class mates. As one girl described:
“We were all standing waiting and the fear was building. Me
and my friend were crying coz we didn’t want to get it. People
were laughing at us. It weren’t funny. And afterwards, we saw
them crying, so we were laughing then” (FG E3: Fran 14).
In almost all of the groups there was also discussion of vari-
ous myths and rumours circulating about the vaccination. These
seemed to stem from the fact that three doses of the vaccine
were required, and the prospect of three injections often became
more daunting as rumours spread. Typical rumours were that each
injection was more painful than the previous one, that the needle
became largerwitheachdose, or that thedosebecame“thicker”and
“larger”. For example, when one girl said: “I’ve been told the third’s
the worst” (FG S4: Clara 16) the other group members nodded and
one replied that she had heard that the third injection was “double
strength and like a bigger needle” (FG S4:Millie 16). Although these
rumours often appeared to have come from other girls, there were
also examples of rumours spread by boys, particularly in relation
to the site of the vaccination: “. . . they [the boys] said that we’d
get it in your bum in your cervix” (FG E2: Joanne 13). Whilst some
girls found these stories worrying others dismissed them. One of
the greatest concerns that the girlsmentionedwas their fear of nee-
dles. Thiswas often of farmore immediate concernwhen theywere
weighing up the pros and cons of vaccination than the possibility
of future cervical cancer. This was succinctly summarised by one
girl who said: “Teenagers, like now, you don’t think you’re going to
get cancer so it’s not important, and you think there’s a needle – oh
my gosh, I’m not going to get this. I’m scared of injections, so you
don’t think about the long term, like it’s going to be really useful”
(FG S4: Bella 16).
Another issue that arose in some groups was the issue of pri-
vacy. Typically, the girls described getting the vaccine in the school
hall or a classroom with partitions which they saw as inadequate.
As one girl recalled: “It wasn’t very private or anything. It was like,
there was a like a pin board and then you behind, not very pri-
vate, especially with the ﬁrst one when you’re a bit worried (FG
S2: Sharron 13). Other girls recalled having forgotten to wear a
vest top and being concerned about having to remove their school
shirts to receive the vaccine. One girl said: “some folk were quite
embarrassed about ‘cause like if you’ve got a long sleeved shirt on,
which most of us did have, cause we wear white shirts, then you
had to actually take their shirt off to get the jag, cause you couldn’t
roll your sleeves up” (FG S8: Megan 16).
The issue of needle cleanliness arose spontaneously in a few
groups and was discussed at length in one group which debated
whether they could trust that the health professionalswould do the
vaccinations in a way which meant that the needles were not acci-
dentally re-sheathed and re-used. Some girls mentioned that the
nurses seemedharassed, and the ‘conveyor belt’methodof delivery
raised concerns about cross infection. A few girls described feeling
anxious at seeing batches of syringes and needles lying on tables,
as illustrated below:
Annie: To be honest, I’m not even sure if it’s [the needle] clean
Izzy: No, I watched her, the nurse to made sure she took a new
needle
Michelle: I know my doctor’s is clean – I’m not sure about the
school. You never know if the cleaners came in that day and they
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put the things for vaccination on the dirty table. Not clean at all.
(FG E9: Annie 15, Izzy 15, Michelle 15)
When girls were asked whether they had been given informa-
ion or the opportunity to allay these concerns, most said they had
ot.
. Discussion and conclusion
Our ﬁndings support those from a similar study by Williams
nd colleagues which used individual interviews to elicit under-
tandings of adolescent girls post HPV vaccination implementation
14]. Consistentwith this study,we found that girls knewvery little
bout HPV prevalence and transmission. These ﬁndings also echo
arlier research on older women’s knowledge about HPV prior to
he introduction of the HPV vaccination programme [7–10]. The
ack of knowledge about HPV prevalence and its transmission is of
oncern because it may impact on future health behaviours. Our
ata suggest that HPV prevalence is underestimated and that as
result girls assess their own likelihood of contracting HPV as
ow, believing that HPV infection was only common among peo-
le who had multiple sexual partners. This notion may have arisen
rom media reporting about HPV and the development of the vac-
ine; somemedia coverage reported concerns thatHPVvaccination
ight increase the risk of promiscuity among adolescents [22],
hilst little news coverage reported that HPV is a highly infectious
nd prevalent virus within the general population, or that around
0% of girls will have contracted HPV by the time they reach 18
ears of age [23].Waller andcolleagueshaveargued that anempha-
is on the high prevalence of HPV in the population may be useful
n helping to increase the acceptability of HPV vaccination if people
erceive the likelihood of contracting HPV infection to be high [24].
In contrast to concerns that in targeting of HPV campaignmate-
ial at sexually active young women, girls could be presumed to be
he source of HPV infection [25], our study found that some girls
iewed boys as the vector of infection. Indeed there was much dis-
ussion among participants about the need for boys to be tested
outinely for HPV as part of STI screening and treated if infection
as detected. This demonstrates how in the event of not know-
ng about HPV infection, participants tended to draw on their other
nowledge about sexually transmitted infections such as chlamy-
ia. It also highlights the level of confusion among some young
eople on what is a complex issue, which may have implications
or how they assess the risks associated with HPV for their health.
f girls assess that their own risk of contracting infection is low
nd that HPV infection could be amenable to treatment, vaccina-
ion could be deemed less important. AlthoughHPV vaccine uptake
s generally high, should uptake rates fall these data suggest that
here is a need to make girls aware of the high prevalence of HPV
nd that their best formof protection is the vaccine. However, these
isunderstandings could also have implications for the uptake of
PV should the programme be rolled out to include boys in the
uture
One limitation of this qualitative study is that the girl’s self-
elected into the study, and that despite advertising for girls who
ad not opted to have the HPV vaccine, we onlymanaged to recruit
ight unvaccinated girls. Nevertheless, this study does offer new
nsights about girls’ concerns and views on HPV and HPV vaccina-
ion which could be used as the basis to conducting a larger scale
epresentative survey to identify which ﬁndings are generalisable.
or example, we found a lack of any anxiety about long-term or
erious side-effects from HPV vaccination and that these adoles-
ent girls trusted their parents, the Government and immunisation
pecialists to make beneﬁcial decisions and recommendations to
rotect their future health. It would be useful explore this ﬁnd-
[
[29 (2011) 4409–4415
ing to pinpoint when anxieties about vaccines start to occur and
trust starts to erode. Roughly half of the girls were also aware that
having the HPV vaccine did not negate the need to attend for cer-
vical screening in the future; this message needs to be reinforced
however for those girls who did not know this. Our research also
suggests that whether girls attend for screening may be depen-
dent on their ownmother’s participation in, and perceptions of the
importanceof, cervical screening. Another pointworthyof address-
ing is that many girls believe that cancer is almost an inevitable
part of life and questionedwhether a vaccine could actually protect
them against cervical cancer. This points to the need to continue to
provide up-to-date information on how effective the HPV vaccine
is estimated to be; if positive new data on HPV vaccine efﬁcacy
emerges this could be promoted through themedia as a good news
story in the battle against cancer [22].
Our study also suggests that it would be worthwhile addressing
adolescents’ concerns about and the process of administering and
receiving the vaccination, and to dispel myths surrounding HPV
vaccination. Concerns about the cleanliness of needles, the size (of
needles) and dose of the vaccine in the second and third doses and
the extent of privacy that girls can expect whilst receiving the vac-
cine could be easily addressed through clear information, and it
is important that these worries do not become barriers to a high
uptake of immunisation.
In conclusion, our data provide some of the ﬁrst insights from
adolescent girls on HPV following the introduction of the UK
HPV vaccination programme in 2008. Our data point to a need
to continue to address gaps in knowledge about HPV and to
provide information on girls’ immediate concerns about HPV vac-
cination. One method of doing this might be through targeted
campaign materials and by ensuring those involved in delivering
the programme are aware of girls’ anxieties so that girls’ limited
knowledge and fears about vaccination do not act as barriers either
to HPV vaccination.
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